Arkolith/Insider Trading/INTS/Form 4

Wesolowski John M

Principal Accounting OfficerINTENSITY THERAPEUTICS, INC. (INTS) · full profile →Form 4 · filed Oct 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 21, 2024Grant(A)70K—$070K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001895944-24-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML